GSK-1795091

N/A

Report date: 2023/12/01 09:29:03
NME

Base Information

Drug NameGSK-1795091
Drug Alias Name1795091GSK-1795091CRX-601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A